Invention Grant
- Patent Title: Multivalent entrain-and-amplify immunotherapeutics for carcinoma
- Patent Title (中): 多重夹带和扩增免疫治疗癌症
-
Application No.: US11455279Application Date: 2006-06-16
-
Publication No.: US08084592B2Publication Date: 2011-12-27
- Inventor: Adrian Ion Bot , Chih-Sheng Chiang , David C. Diamond , Jian Gong , Kent Andrew Smith , Liping Liu , Xiping Liu , Zhiyong Qiu
- Applicant: Adrian Ion Bot , Chih-Sheng Chiang , David C. Diamond , Jian Gong , Kent Andrew Smith , Liping Liu , Xiping Liu , Zhiyong Qiu
- Applicant Address: US CA Valencia
- Assignee: MannKind Corporation
- Current Assignee: MannKind Corporation
- Current Assignee Address: US CA Valencia
- Agency: Davis Wright Tremaine LLP
- Main IPC: C07H21/02
- IPC: C07H21/02
Abstract:
The present invention provides a method of treating a cell proliferative disease such as cancer by providing to a subject in need thereof an immunogenic composition comprising plasmid and peptide(s) or analogues thereof. In embodiments of the present invention there is provided methods and compositions for inducing, entraining, and/or amplifying the immune response to MHC class-I restricted epitopes of carcinoma antigens to generate an effective anti-cancer immune response.
Public/Granted literature
- US20070003563A1 Multivalent entrain-and-amplify immunotherapeutics for carcinoma Public/Granted day:2007-01-04
Information query
